{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:21:26Z","timestamp":1790882486044,"version":"4.1.0"},"reference-count":160,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Extranodal NK\/T-cell lymphoma is a neoplasm of NK cells or cytotoxic T cells presenting in extranodal sites, most often in the nasal cavity. The typical immunophenotypes are cCD3+, sCD3\u2212, CD4\u2212, CD5\u2212, CD8\u2212, CD16\u2212, and CD56+ with the expression of cytotoxic molecules. Tumor subsets express NK cell receptors, CD95\/CD95L, CD30, MYC, and PDL1. Virtually all the tumor cells harbor the EBV genome, which plays a key role in lymphomagenesis as an epigenetic driver. EBV-encoded oncoproteins modulate the host-cell epigenetic machinery, reprogramming the viral and host epigenomes using host epigenetic modifiers. NGS analysis revealed the mutational landscape of ENKTL, predominantly involving the JAK\u2013STAT pathway, epigenetic modifications, the RNA helicase family, the RAS\/MAP kinase pathway, and tumor suppressors, which indicate an important role of these pathways and this group of genes in the lymphomagenesis of ENKTL. Recently, three molecular subtypes were proposed, the tumor-suppressor\/immune-modulator (TSIM), MGA-BRDT (MB), and HDAC9-EP300-ARID1A (HEA) subtypes, and they are well-correlated with the cell of origin, EBV pattern, genomic alterations, and clinical outcomes. A future investigation into the function and interaction of discovered genes would be very helpful for better understanding the molecular pathogenesis of ENKTL and establishing better treatment strategies.<\/jats:p>","DOI":"10.3390\/life12010073","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T01:14:02Z","timestamp":1641518042000},"page":"73","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The Pathologic and Genetic Characteristics of Extranodal NK\/T-Cell Lymphoma"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8935-7414","authenticated-orcid":false,"given":"Hyunsung","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Pathology, Hanyang University College of Medicine, Seoul 04763, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hyeh","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hanyang University College of Medicine, Seoul 04763, Korea"},{"name":"Department of Pathology, Guro Hospital Korea University, Seoul 08308, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"key":"ref_1","unstructured":"Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J., and Vardiman, J.W. (2017). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, IARC Press."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1017\/S0022215100118407","article-title":"Photographs of a case of rapid destruction of the nose and face. 1897","volume":"105","author":"McBride","year":"1991","journal-title":"J. Laryngol. Otol."},{"key":"ref_3","first-page":"43","article-title":"Uber ein eigenartiges granulom aer nasen-, rachen-und mundhohle","volume":"24","author":"Kraus","year":"1929","journal-title":"Verh. Dtsch. Ges. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0002-9610(66)90328-X","article-title":"Primary lymphoma of the nose including a relationship to lethal midline granuloma","volume":"112","author":"Eichel","year":"1966","journal-title":"Am. J. Surg."},{"key":"ref_5","first-page":"50","article-title":"Reticulum cell sarcoma; reticulum cell sarcoma of the frontal sinus","volume":"5","author":"Lachmann","year":"1946","journal-title":"Acta Med. Orient."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/1097-0142(196904)23:4<920::AID-CNCR2820230430>3.0.CO;2-M","article-title":"Midline malignant reticulosis (so-called lethal midline granuloma)","volume":"23","author":"Kassel","year":"1969","journal-title":"Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/07357908409040316","article-title":"Pathologic and clinical spectrum of post-thymic T-cell malignancies","volume":"2","author":"Jaffe","year":"1984","journal-title":"Cancer Investig."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1182\/blood.V72.5.1674.1674","article-title":"Angiocentric immunoproliferative lesions: A clinicopathologic spectrum of post-thymic T-cell proliferations","volume":"72","author":"Lipford","year":"1988","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1001\/archinte.1959.00270010122016","article-title":"Lethal midline granuloma of the face: Report of case and review of the literature","volume":"103","author":"Resnick","year":"1959","journal-title":"AMA Arch. Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1002\/1097-0142(19821201)50:11<2336::AID-CNCR2820501120>3.0.CO;2-C","article-title":"Nasal T-cell lymphoma as a type of so-called \u201clethal midline granuloma\u201d","volume":"50","author":"Ishii","year":"1982","journal-title":"Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0140-6736(90)90002-M","article-title":"Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma","volume":"335","author":"Harabuchi","year":"1990","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1182\/blood.V83.8.2255.2255","article-title":"Expression of adult and fetal natural killer cell markers in sinonasal lymphomas","volume":"83","author":"Suzumiya","year":"1994","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00000478-199601000-00012","article-title":"Report of the Workshop on Nasal and Related Extranodal Angiocentric T\/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology","volume":"20","author":"Jaffe","year":"1996","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_15","unstructured":"Jaffe, E.S., Harris, N.L., Stein, H., and Vardiman, J. (2001). WHO Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, IARC Press. [3rd ed.]."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0b013e31826731b5","article-title":"Extranodal NK\/T-cell lymphoma, nasal type: A report of 73 cases at MD Anderson Cancer Center","volume":"37","author":"Li","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/his.12990","article-title":"Small-cell predominant extranodal NK\/T cell lymphoma, nasal type: Clinicopathological analysis of a series of cases diagnosed in a Western population","volume":"69","author":"McKelvie","year":"2016","journal-title":"Histopathology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0002-9440(10)63061-1","article-title":"p53 Mutations in nasal natural killer\/T-cell lymphoma from Mexico: Association with large cell morphology and advanced disease","volume":"159","author":"Kremer","year":"2001","journal-title":"Am. J. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"103237","DOI":"10.1016\/j.critrevonc.2021.103237","article-title":"Extranodal NK\/T cell lymphoma, nasal type: An updated overview","volume":"159","author":"Carlos","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/modpathol.3800157","article-title":"Nasal-type extranodal natural killer\/T-cell lymphomas: A clinicopathologic and genotypic study of 42 cases in Singapore","volume":"17","author":"Ng","year":"2004","journal-title":"Mod. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1309\/V561QTM6854W4WAV","article-title":"Immunohistochemical characterization of nasal-type extranodal NK\/T-cell lymphoma using a tissue microarray: An analysis of 84 cases","volume":"130","author":"Schwartz","year":"2008","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/10428194.2010.543718","article-title":"Immunophenotypic characteristics and clinical relevance of CD56+ and CD56- extranodal nasal-type natural killer\/T-cell lymphoma","volume":"52","author":"Li","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1182\/blood.V95.11.3628","article-title":"Expression of CD94\/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas","volume":"95","author":"Haedicke","year":"2000","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood-2003-01-0295","article-title":"CD94 transcripts imply a better prognosis in nasal-type extranodal NK\/T-cell lymphoma","volume":"102","author":"Lin","year":"2003","journal-title":"Blood"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00428-020-02776-x","article-title":"CD20-positive extranodal NK\/T cell lymphoma: Clinicopathologic and prognostic features","volume":"477","author":"Huang","year":"2020","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1746-1596-7-133","article-title":"CD20-positive NK\/T-cell lymphoma with indolent clinical course: Report of case and review of literature","volume":"7","author":"Jiang","year":"2012","journal-title":"Diagn. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/modpathol.3880133","article-title":"Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T- (NK\/T-) cell lymphomas","volume":"13","author":"Blakolmer","year":"2000","journal-title":"Mod. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1746-1596-6-79","article-title":"Aberrant antigenic expression in extranodal NK\/T-cell lymphoma: A multi-parameter study from Thailand","volume":"6","author":"Pongpruttipan","year":"2011","journal-title":"Diagn. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0046-8177(99)90299-X","article-title":"Peripheral T and putative natural killer cell lymphomas commonly coexpress CD95 and CD95 ligand","volume":"30","author":"Ng","year":"1999","journal-title":"Hum. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.yexmp.2017.06.008","article-title":"The clinical significance of c-MYC expression, rearrangement, and copy number gain in extranodal NK\/T-cell lymphoma: A retrospective study in China","volume":"103","author":"Chen","year":"2017","journal-title":"Exp. Mol. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/PAS.0000000000000365","article-title":"Expression profiles of MYC protein and MYC gene rearrangement in lymphomas","volume":"39","author":"Chisholm","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/hon.2482","article-title":"Frequent expression of CD30 in extranodal NK\/T-cell lymphoma: Potential therapeutic target for anti-CD30 antibody-based therapy","volume":"36","author":"Kawamoto","year":"2018","journal-title":"Hematol. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1517\/13543776.2013.768985","article-title":"PTEN modulators: A patent review","volume":"23","author":"Boosani","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Fu, X., Zhang, X., Gao, J., Li, X., Zhang, L., Li, L., Wang, X., Sun, Z., Li, Z., and Chang, Y. (2017). Phosphatase and tensin homolog (PTEN) is down-regulated in human NK\/T-cell lymphoma and corrects with clinical outcomes. Medicine, 96.","DOI":"10.1097\/MD.0000000000007111"},{"key":"ref_35","first-page":"7034","article-title":"Selection of new immunotherapy targets for NK\/T cell lymphoma","volume":"12","author":"Lv","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"De Mel, S., Soon, G.S., Mok, Y., Chung, T.H., Jeyasekharan, A.D., Chng, W.J., and Ng, S.B. (2018). The Genomics and Molecular Biology of Natural Killer\/T-Cell Lymphoma: Opportunities for Translation. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19071931"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00277-016-2818-4","article-title":"Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK\/T-cell lymphoma, nasal type","volume":"96","author":"Jo","year":"2017","journal-title":"Ann. Hematol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000500974","article-title":"Programmed Cell Death 1 and Programmed Cell Death Ligands in Extranodal Natural Killer\/T Cell Lymphoma: Expression Pattern and Potential Prognostic Relevance","volume":"143","author":"Muhamad","year":"2020","journal-title":"Acta Haematol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00428-016-2011-0","article-title":"Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK\/T cell lymphoma is associated with better prognosis","volume":"469","author":"Kim","year":"2016","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1038\/s41375-021-01313-2","article-title":"NK-\/T-cell lymphomas","volume":"35","author":"Wang","year":"2021","journal-title":"Leukemia"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0046-8177(96)90401-3","article-title":"Differences in T-cell-receptor gene rearrangement and transcription in nasal lymphomas of natural killer and T-cell types: Implications on cellular origin","volume":"27","author":"Chiang","year":"1996","journal-title":"Hum. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1440-1827.1997.tb04433.x","article-title":"Clinicopathologic study of nasal T\/NK-cell lymphoma among the Japanese","volume":"47","author":"Nakamura","year":"1997","journal-title":"Pathol. Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0046-8177(99)90219-8","article-title":"Cases of cutaneous and nasal CD56 (NCAM)-positive lymphoma in Japan have differences in immunohistology, genotype, and etiology","volume":"30","author":"Takeshita","year":"1999","journal-title":"Hum. Pathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/hon.2900080505","article-title":"Presence of Epstein-Barr virus DNA in nasal lymphomas of B and \u201cT\u201d cell type","volume":"8","author":"Ho","year":"1990","journal-title":"Hematol. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/(SICI)1097-0215(19971104)73:3<332::AID-IJC5>3.0.CO;2-0","article-title":"Nasal T\/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage","volume":"73","author":"Chiang","year":"1997","journal-title":"Int. J. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/(SICI)1097-0215(19990611)81:6<865::AID-IJC5>3.0.CO;2-S","article-title":"Immunophenotypic and genotypic characterization of nasal lymphoma with polymorphic reticulosis morphology","volume":"81","author":"Ohsawa","year":"1999","journal-title":"Int. J. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/1097-0142(20001115)89:10<2106::AID-CNCR11>3.0.CO;2-G","article-title":"Clinicopathologic and genotypic study of extranodal nasal-type natural killer\/T-cell lymphoma and natural killer precursor lymphoma among Koreans","volume":"89","author":"Ko","year":"2000","journal-title":"Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.3109\/10428194.2013.871634","article-title":"Detection of T-cell receptor \u03b3 gene rearrangement in paraffin-embedded T or natural killer\/T-cell lymphoma samples using the BIOMED-2 protocol","volume":"55","author":"Takata","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3109\/10428191003660631","article-title":"BIOMED-2 protocols to detect clonal immunoglobulin and T-cell receptor gene rearrangements in B- and T-cell lymphomas in southern Taiwan","volume":"51","author":"Chen","year":"2010","journal-title":"Leuk. Lymphoma"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/modpathol.2016.47","article-title":"Nasal-type NK\/T-cell lymphomas are more frequently T rather than NK lineage based on T-cell receptor gene, RNA, and protein studies: Lineage does not predict clinical behavior","volume":"29","author":"Hong","year":"2016","journal-title":"Mod. Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/PAS.0b013e31824433d8","article-title":"Extranodal NK\/T-cell lymphoma, nasal type, includes cases of natural killer cell and \u03b1\u03b2, \u03b3\u03b4, and \u03b1\u03b2\/\u03b3\u03b4 T-cell origin: A comprehensive clinicopathologic and phenotypic study","volume":"36","author":"Pongpruttipan","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0002-9440(10)63014-3","article-title":"Restricted killer cell immunoglobulin-like receptor repertoire without T-cell receptor gamma rearrangement supports a true natural killer-cell lineage in a subset of sinonasal lymphomas","volume":"159","author":"Lin","year":"2001","journal-title":"Am. J. Pathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13045-017-0452-9","article-title":"The diagnosis and management of NK\/T-cell lymphomas","volume":"10","author":"Tse","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.humpath.2015.03.002","article-title":"Epstein-Barr virus-positive nodal T\/NK-cell lymphoma: An analysis of 15 cases with distinct clinicopathological features","volume":"46","author":"Jeon","year":"2015","journal-title":"Hum. Pathol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3960\/jslrt.20001","article-title":"Nodal EBV+ cytotoxic T-cell lymphoma: A literature review based on the 2017 WHO classification","volume":"60","author":"Kato","year":"2020","journal-title":"J. Clin. Exp. Hematop."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: Prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/annonc\/mdp418","article-title":"Prognostic factors for mature natural killer (NK) cell neoplasms: Aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type","volume":"21","author":"Suzuki","year":"2010","journal-title":"Ann. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fped.2018.00292","article-title":"Aggressive NK-Cell Leukemia","volume":"6","author":"Ishida","year":"2018","journal-title":"Front. Pediatr."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/PAS.0000000000001518","article-title":"Genomic and Immunophenotypic Landscape of Aggressive NK-Cell Leukemia","volume":"44","author":"Patel","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/hon.776","article-title":"Intravascular lymphoma: A neoplasm of \u201chomeless\u201d lymphocytes?","volume":"24","author":"Ponzoni","year":"2006","journal-title":"Hematol. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/cncr.11107","article-title":"Cytotoxic\/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop","volume":"97","author":"Santucci","year":"2003","journal-title":"Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood-2017-05-785857","article-title":"Intravascular large cell lymphoma of NK\/T-cell type, EBV positive","volume":"130","author":"Okonkwo","year":"2017","journal-title":"Blood"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/his.13332","article-title":"Cutaneous intravascular natural killer\/T cell lymphoma with peculiar immunophenotype","volume":"71","author":"Manzarbeitia","year":"2017","journal-title":"Histopathology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1182\/blood-2018-06-856724","article-title":"A rare case of renal intravascular NK\/T-cell lymphoma","volume":"132","author":"Elshiekh","year":"2018","journal-title":"Blood"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/jclinpath-2019-205727","article-title":"Intravascular NK\/T-cell lymphoma: Clinicopathological and integrated molecular analysis of two cases provides a clue to disease pathogenesis","volume":"72","author":"Fujikura","year":"2019","journal-title":"J. Clin. Pathol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1046\/j.1365-2141.1997.3223139.x","article-title":"Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma\/leukaemia","volume":"98","author":"Wong","year":"1997","journal-title":"Br. J. Haematol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0002-9440(10)64818-3","article-title":"Consistent patterns of allelic loss in natural killer cell lymphoma","volume":"157","author":"Siu","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1080\/1042819031000123410","article-title":"Deletion mapping of the long arm of chromosome 6 in peripheral T and NK cell lymphomas","volume":"44","author":"Yoon","year":"2003","journal-title":"Leuk. Lymphoma"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/gcc.20245","article-title":"Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma\/leukemia: Different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk\/T-cell lymphoma, nasal type","volume":"44","author":"Nakashima","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0002-9440(10)65454-5","article-title":"Comparative genomic hybridization analysis of natural killer cell lymphoma\/leukemia. Recognition of consistent patterns of genetic alterations","volume":"155","author":"Siu","year":"1999","journal-title":"Am. J. Pathol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1046\/j.1365-2141.2003.04419.x","article-title":"A 2.6 Mb interval on chromosome 6q25.2-q25.3 is commonly deleted in human nasal natural killer\/T-cell lymphoma","volume":"122","author":"Sun","year":"2003","journal-title":"Br. J. Haematol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/cyto.1069","article-title":"Comparative genomic hybridization study of nasal-type NK\/T-cell lymphoma","volume":"46","author":"Ko","year":"2001","journal-title":"Cytometry"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","article-title":"Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type","volume":"115","author":"Huang","year":"2010","journal-title":"Blood"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2009.3","article-title":"Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies","volume":"23","author":"Iqbal","year":"2009","journal-title":"Leukemia"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.exphem.2012.08.005","article-title":"Lineage-specific growth inhibition of NK cell lines by FOXO3 in association with Akt activation status","volume":"40","author":"Karube","year":"2012","journal-title":"Exp. Hematol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1182\/blood-2011-04-346890","article-title":"Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses","volume":"118","author":"Karube","year":"2011","journal-title":"Blood"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"20119","DOI":"10.1073\/pnas.1115128108","article-title":"PRDM1 is a tumor suppressor gene in natural killer cell malignancies","volume":"108","author":"Iqbal","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1080\/15548627.2016.1199301","article-title":"Metastatic risk and resistance to BRAF inhibitors in melanoma defined by selective allelic loss of ATG5","volume":"12","author":"Karras","year":"2016","journal-title":"Autophagy"},{"key":"ref_79","first-page":"5449","article-title":"Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma","volume":"51","author":"Millikin","year":"1991","journal-title":"Cancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/labinvest.3780055","article-title":"Mutations of the p53 gene in nasal NK\/T-cell lymphoma","volume":"80","author":"Li","year":"2000","journal-title":"Lab. Investig."},{"key":"ref_81","first-page":"265","article-title":"p53, K-ras, c-kit and beta-catenin gene mutations in sinonasal NK\/T-cell lymphoma in Korea and Japan","volume":"13","author":"Hongyo","year":"2005","journal-title":"Oncol. Rep."},{"key":"ref_82","first-page":"1257","article-title":"Gene mutation analysis of sinonasal lymphomas in Indonesia","volume":"15","author":"Kurniawan","year":"2006","journal-title":"Oncol. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1349-7006.2006.00226.x","article-title":"Alterations in ATR in nasal NK\/T-cell lymphoma and chronic active Epstein-Barr virus infection","volume":"97","author":"Liu","year":"2006","journal-title":"Cancer Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1158\/2159-8290.CD-12-0028","article-title":"Janus kinase 3-activating mutations identified in natural killer\/T-cell lymphoma","volume":"2","author":"Koo","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5808\/GI.2016.14.3.78","article-title":"Mutational Analysis of Extranodal NK\/T-Cell Lymphoma Using Targeted Sequencing with a Comprehensive Cancer Panel","volume":"14","author":"Choi","year":"2016","journal-title":"Genomics Inform."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/gcc.22348","article-title":"Frequent BCOR aberrations in extranodal NK\/T-Cell lymphoma, nasal type","volume":"55","author":"Dobashi","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1080\/15384047.2019.1638670","article-title":"Somatic mutations in KMT2D and TET2 associated with worse prognosis in Epstein-Barr virus-associated T or natural killer-cell lymphoproliferative disorders","volume":"20","author":"Gao","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ng.3358","article-title":"Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma","volume":"47","author":"Jiang","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/ncomms7025","article-title":"Activating mutations of STAT5B and STAT3 in lymphomas derived from gammadelta-T or NK cells","volume":"6","author":"Kucuk","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"17764","DOI":"10.18632\/oncotarget.3776","article-title":"Genetic alterations of JAK\/STAT cascade and histone modification in extranodal NK\/T-cell lymphoma nasal type","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ccell.2020.02.005","article-title":"Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma","volume":"37","author":"Xiong","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nm.4456","article-title":"Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK\/T cell lymphoma","volume":"24","author":"Wen","year":"2018","journal-title":"Nat. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/gcc.22249","article-title":"Integrated copy number and gene expression profiling analysis of Epstein-Barr virus-positive diffuse large B-cell lymphoma","volume":"54","author":"Yoon","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ng.982","article-title":"Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer","volume":"43","author":"Wang","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.3389\/fimmu.2019.02590","article-title":"JAK\/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation","volume":"10","author":"Gotthardt","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tcb.2008.08.008","article-title":"Canonical and non-canonical JAK-STAT signaling","volume":"18","author":"Li","year":"2008","journal-title":"Trends Cell Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.biocel.2009.09.004","article-title":"JAK3: A two-faced player in hematological disorders","volume":"41","author":"Cornejo","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3109\/10428194.2013.819577","article-title":"Rare occurrence of JAK3 mutations in natural killer cell neoplasms in Japan","volume":"55","author":"Kimura","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.ajpath.2017.01.004","article-title":"Novel JAK3-Activating Mutations in Extranodal NK\/T-Cell Lymphoma, Nasal Type","volume":"187","author":"Sim","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/leu.2013.157","article-title":"JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma","volume":"28","author":"Bouchekioua","year":"2014","journal-title":"Leukemia"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00024382-200202000-00001","article-title":"Suppressors of cytokine signaling (SOCS): Inhibitors of the JAK\/STAT pathway","volume":"17","author":"Cooney","year":"2002","journal-title":"Shock"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/ijc.27318","article-title":"Role of SOCS1 in tumor progression and therapeutic application","volume":"130","author":"Zhang","year":"2012","journal-title":"Int. J. Cancer"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1073\/pnas.96.5.2071","article-title":"The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation","volume":"96","author":"Zhang","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1182\/blood-2014-07-588970","article-title":"Receptor-type tyrosine-protein phosphatase \u03ba directly targets STAT3 activation for tumor suppression in nasal NK\/T-cell lymphoma","volume":"125","author":"Chen","year":"2015","journal-title":"Blood"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.canlet.2019.05.024","article-title":"COMPASS Ascending: Emerging clues regarding the roles of MLL3\/KMT2C and MLL2\/KMT2D proteins in cancer","volume":"458","author":"Fagan","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1038\/s41375-019-0473-1","article-title":"Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling","volume":"33","author":"Watatani","year":"2019","journal-title":"Leukemia"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Mosquera Orgueira, A., Ferreiro Ferro, R., D\u00edaz Arias, J., Aliste Santos, C., Antelo Rodr\u00edguez, B., Bao P\u00e9rez, L., Alonso Vence, N., Benda\u00f1a L\u00f3pez, \u00c1., Abuin Blanco, A., and Melero Valent\u00edn, P. (2021). Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0248886"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1101\/gad.14.14.1810","article-title":"BCoR, a novel corepressor involved in BCL-6 repression","volume":"14","author":"Huynh","year":"2000","journal-title":"Genes Dev."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrm4067","article-title":"Targeting Polycomb systems to regulate gene expression: Modifications to a complex story","volume":"16","author":"Blackledge","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/BST20160173","article-title":"Molecular architecture of polycomb repressive complexes","volume":"45","author":"Chittock","year":"2017","journal-title":"Biochem Soc. Trans."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/leu.2016.2","article-title":"BCOR regulates myeloid cell proliferation and differentiation","volume":"30","author":"Cao","year":"2016","journal-title":"Leukemia"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ccell.2016.07.006","article-title":"EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis","volume":"30","author":"Teater","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.4049\/jimmunol.1500201","article-title":"Cutting edge: Bcl6-interacting corepressor contributes to germinal center T follicular helper cell formation and B cell helper function","volume":"194","author":"Yang","year":"2015","journal-title":"J. Immunol."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Sportoletti, P., Sorcini, D., and Falini, B. (2021). BCOR gene alterations in hematological diseases. Blood, in press.","DOI":"10.1182\/blood.2021010958"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Kang, J.H., Lee, S.H., Lee, J., Choi, M., Cho, J., Kim, S.J., Kim, W.S., Ko, Y.H., and Yoo, H.Y. (2021). The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-07806-8"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1158\/1078-0432.CCR-14-1216","article-title":"Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma","volume":"21","author":"Hu","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"636","DOI":"10.4149\/neo_2020_190307N194","article-title":"KMT2D and TP53 mutation status improve the prognostic value of the International Prognostic Index (IPI) stratification in ENKTL patients","volume":"67","author":"Gao","year":"2020","journal-title":"Neoplasma"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"a026534","DOI":"10.1101\/cshperspect.a026534","article-title":"Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer","volume":"7","author":"Attar","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ymgme.2016.06.013","article-title":"CBP\/p300 acetyltransferase activity in hematologic malignancies","volume":"119","author":"Dutta","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41392-020-00331-3","article-title":"Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer\/T cell lymphoma","volume":"5","author":"Cai","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4161\/cbt.28411","article-title":"The emerging roles of ARID1A in tumor suppression","volume":"15","author":"Wu","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.humpath.2003.08.025","article-title":"P53, N- and K-Ras, and beta-catenin gene mutations and prognostic factors in nasal NK\/T-cell lymphoma from Hokkaido, Japan","volume":"35","author":"Takahara","year":"2004","journal-title":"Hum. Pathol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1349-7006.2003.tb01436.x","article-title":"Analysis of p53, K-ras, c-kit, and beta-catenin gene mutations in sinonasal NK\/T cell lymphoma in northeast district of China","volume":"94","author":"Hoshida","year":"2003","journal-title":"Cancer Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.humpath.2018.05.026","article-title":"TP53 mutations in peripheral mature T and NK cell lymphomas: A whole-exome sequencing study with correlation to p53 expression","volume":"80","author":"Huang","year":"2018","journal-title":"Hum. Pathol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1158\/1541-7786.MCR-19-0657","article-title":"Multi-Omics Analysis Identifies MGA as a Negative Regulator of the MYC Pathway in Lung Adenocarcinoma","volume":"18","author":"Llabata","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3109\/10428194.2012.723706","article-title":"MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia","volume":"54","author":"Cerri","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0955-0674(97)80061-0","article-title":"Mitogen-activated protein kinase pathways","volume":"9","author":"Robinson","year":"1997","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/jid.2013.365","article-title":"Somatic mutations in MAP3K5 attenuate its proapoptotic function in melanoma through increased binding to thioredoxin","volume":"134","author":"Prickett","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/PAS.0000000000001174","article-title":"An Immune Suppression-associated EBV-positive Anaplastic Large Cell Lymphoma with a BRAF V600E Mutation","volume":"43","author":"Gru","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/35074604","article-title":"Activation of EphA receptor tyrosine kinase inhibits the Ras\/MAPK pathway","volume":"3","author":"Miao","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.4049\/jimmunol.176.7.4066","article-title":"EphA receptors inhibit anti-CD3-induced apoptosis in thymocytes","volume":"176","author":"Freywald","year":"2006","journal-title":"J. Immunol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"6010","DOI":"10.1158\/0008-5472.CAN-19-0615","article-title":"Integrated Pan-Cancer Map of EBV-Associated Neoplasms Reveals Functional Host-Virus Interactions","volume":"79","author":"Chakravorty","year":"2019","journal-title":"Cancer Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"190187","DOI":"10.1098\/rsob.190187","article-title":"Notch signalling in T cell homeostasis and differentiation","volume":"9","author":"Brandstadter","year":"2019","journal-title":"Open Biol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood-2016-09-692582","article-title":"The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia","volume":"129","author":"Ferrando","year":"2017","journal-title":"Blood"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<473::AID-IMMU473>3.0.CO;2-E","article-title":"Quantitative control of MHC class II expression by the transactivator CIITA","volume":"28","author":"Otten","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.2019001126","article-title":"Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma","volume":"134","author":"Mottok","year":"2019","journal-title":"Blood"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"620435","DOI":"10.3389\/fonc.2021.620435","article-title":"Case Report: Multiple Chromosomal Translocations Including Novel CIITA-CREBBP Fusion and Mutations in a Follicular Lymphoma","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"100855","DOI":"10.1016\/j.tranon.2020.100855","article-title":"Identification of clinical molecular targets for childhood Burkitt lymphoma","volume":"13","author":"Zhang","year":"2020","journal-title":"Transl. Oncol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"8583","DOI":"10.18632\/oncotarget.2323","article-title":"Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma","volume":"5","author":"Chiu","year":"2014","journal-title":"Oncotarget"},{"key":"ref_142","unstructured":"Ranger-Rogez, S. EBV Genome Mutations and Malignant Proliferations, IntechOpen. Available online: https:\/\/www.intechopen.com\/online-first\/73024."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Li, L., Ma, B.B.Y., Chan, A.T.C., Chan, F.K.L., Murray, P., and Tao, Q. (2018). Epstein-Barr Virus-Induced Epigenetic Pathogenesis of Viral-Associated Lymphoepithelioma-Like Carcinomas and Natural Killer\/T-Cell Lymphomas. Pathogens, 7.","DOI":"10.3390\/pathogens7030063"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1158\/0008-5472.CAN-08-3070","article-title":"Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma","volume":"69","author":"Hino","year":"2009","journal-title":"Cancer Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1182\/blood-2006-05-020545","article-title":"Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells","volume":"109","author":"Dutton","year":"2007","journal-title":"Blood"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1093\/nar\/gks391","article-title":"BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV","volume":"40","author":"Paschos","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e6467","DOI":"10.1073\/pnas.1605884113","article-title":"Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells","volume":"113","author":"Albanese","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/ni.2537","article-title":"MicroRNAs as mediators of viral evasion of the immune system","volume":"14","author":"Cullen","year":"2013","journal-title":"Nat. Immunol."},{"key":"ref_149","first-page":"71","article-title":"Chromatin Structure of Epstein-Barr Virus Latent Episomes","volume":"390","author":"Lieberman","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0304-3835(97)00368-6","article-title":"Integrated and episomal forms of Epstein-Barr virus (EBV) in EBV associated disease","volume":"122","author":"Ohshima","year":"1998","journal-title":"Cancer Lett."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41375-018-0324-5","article-title":"Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma","volume":"33","author":"Peng","year":"2019","journal-title":"Leukemia"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/cr.2017.146","article-title":"Integrated genomic analysis identifies deregulated JAK\/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia","volume":"28","author":"Huang","year":"2018","journal-title":"Cell Res."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41467-018-03987-2","article-title":"Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target","volume":"9","author":"Dufva","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.prp.2013.04.013","article-title":"Epstein-Barr virus-positive nodal peripheral T cell lymphomas: Clinicopathologic and gene expression profiling study","volume":"209","author":"Ha","year":"2013","journal-title":"Pathol. Res. Pract."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3324\/haematol.2017.180430","article-title":"Epstein-Barr virus-associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes","volume":"103","author":"Ng","year":"2018","journal-title":"Haematologica"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood-2012-06-435297","article-title":"STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia","volume":"120","author":"Jerez","year":"2012","journal-title":"Blood"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/cas.12341","article-title":"STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia","volume":"105","author":"Ishida","year":"2014","journal-title":"Cancer Sci."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/ejh.13038","article-title":"Chronic lymphoproliferative disorder of NK-cells: A single-institution review with emphasis on relative utility of multimodality diagnostic tools","volume":"100","author":"Kurt","year":"2018","journal-title":"Eur. J. Haematol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1182\/blood.2020006721","article-title":"Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells","volume":"137","author":"Pastoret","year":"2021","journal-title":"Blood"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1182\/blood.2020005831","article-title":"Frequent somatic TET2 mutations in chronic NK-LGL leukemia with distinct patterns of cytopenias","volume":"138","author":"Olson","year":"2021","journal-title":"Blood"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/1\/73\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:00:28Z","timestamp":1760364028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/1\/73"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":160,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["life12010073"],"URL":"https:\/\/doi.org\/10.3390\/life12010073","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,5]]}}}